Deirisa Lopes Barreto

Early Diagnostic Markers for Encapsulating Peritoneal Sclerosis: A Case-Control Study

Denise E. Sampimon, Deirisa Lopes Barreto, Anniek Vlijm et al. · Peritoneal Dialysis International · 2010 · 94 citations

Medicine, Immunology, Nephrology +13

Can Effluent Matrix Metalloproteinase 2 and Plasminogen Activator Inhibitor 1 be Used as Biomarkers of Peritoneal Membrane Alterations in Peritoneal Dialysis Patients?

Deirisa Lopes Barreto, Annemieke M. Coester, Dirk G. Struijk et al. · Peritoneal Dialysis International · 2013 · 43 citations

Medicine, Pathobiology, Pathology +17

Peritoneal Effluent MMP-2 and PAI-1 in Encapsulating Peritoneal Sclerosis

Deirisa Lopes Barreto, Dirk G. Struijk, Raymond T. Krediet · American Journal of Kidney Diseases · 2014 · 42 citations

Medicine, Cell Biology, Surgery +5

Variability of effluent cancer antigen 125 and interleukin-6 determination in peritoneal dialysis patients

Deirisa Lopes Barreto, Annemieke M. Coester, Marlies Noordzij et al. · Nephrology Dialysis Transplantation · 2011 · 35 citations · Full text

Medicine, Immunology, Cancer Immunology +12

Induction of Chronic Kidney Failure in a Long-Term Peritoneal Exposure Model in the Rat: Effects on Functional and Structural Peritoneal Alterations

François Vrtovsnik, Annemieke M. Coester, Deirisa Lopes Barreto et al. · Peritoneal Dialysis International · 2010 · 23 citations

Medicine, Nephrology, Dialysis +10